15 Superfoods For An Edge Up On Weight Loss-Blackdoctor

(HealthDay News) — The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating obstructive sleep apnea (OSA): the weight-loss drug Zepbound. In a news release published Dec. 20, the FDA stated that Zepbound, part read more about This Weight Loss Drug Could Also Treat Sleep Apnea

(HealthDay News) — Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical trial funded by Lilly. "Given the increased interest around obesity medications, we conducted this study to help read more about Zepbound Outperforms Wegovy in Weight Loss Clinical Trial